F-star Seals $21.7M in Fresh Capital
Vienna-based biopharma company f-star GmbH has raised 15 million euro ($21.7 million) in a new financing round led by SR One, the corporate venture capital arm of GlaxoSmithKline. Existing shareholder Atlas Venture, Aescap Venture, Novo Ventures, TVM Capital, Merck Serono Ventures and MP Healthcare Venture Management also participated in the round. As a result, SR One Partner Dr Deborah Harland and Dr Axel Polack of TVM Capital will join f-star's Supervisory Board.
13 April 2011•5 mins read
